Muscle Capillarization and Sarcopenia

January 23, 2024 updated by: Steven J. Prior, Ph.D., Baltimore VA Medical Center

Increasing Muscle Capillarization to Enhance Responses to Strength Training in Sarcopenia

Aging is associated with a loss of muscle mass, termed sarcopenia, that reduces mobility, decreases physical function and accelerates progression of other age-related disorders. This study is designed to determine whether increasing skeletal muscle capillarization through aerobic exercise will enhance muscular adaptations to strength training in older adults with sarcopenia.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Sarcopenia, or the aging-related loss of muscle mass, affects a large number of older adults. The presence of sarcopenia is associated with physical disability, poor quality of life, and all-cause mortality, in part because sarcopenic adults have low muscle skeletal muscle capillarization and may lack the adequate perfusion needed to maintain muscle mass and function. This study will test the effects of increasing skeletal muscle capillarization through aerobic exercise training on responses to resistance training in older adults. Eligible participants will be randomized to one of two groups, resistance training preceded by aerobic exercise training (AEX-RT), or resistance training followed by aerobic exercise training (RT-AEX). Participants in the AEX-RT group will undergo 3 months of aerobic exercise training to increase skeletal muscle capillarization, followed by 3 months of resistance training. Participants in the RT-AEX group will undergo 3 months of resistance training, followed by 3 months of aerobic exercise training. Before and after the interventions, participants will undergo assessments of muscle size, strength, and capillarization, as well as assessments of physical function.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21201
        • University of Maryland, Baltimore & Baltimore VA Medical Center
      • College Park, Maryland, United States, 20742
        • University of Maryland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 88 years (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body Mass Index = 18-32.5 kg/m2
  • Non-smoker
  • Presence of at least moderate sarcopenia (low muscle mass per unit body height)

Exclusion Criteria:

  • Diagnosis of diabetes, cancer, pulmonary or renal disease
  • Physical impairment preventing exercise
  • Recent history of exercise training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic exercise training followed by resistance training
Participants in this arm will undergo 3 months of aerobic exercise training, followed by 3 months of strength training
3 months of center-based, supervised treadmill exercise
3 months of center-based, supervise strength training
Active Comparator: Resistance training followed by aerobic exercise training
Participants in this arm will undergo 3 months of strength training, followed by 3 months of aerobic exercise training
3 months of center-based, supervised treadmill exercise
3 months of center-based, supervise strength training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skeletal muscle capillarization
Time Frame: 6 months
Change in the number of capillaries per unit of skeletal muscle tissue
6 months
Muscle volume
Time Frame: 6 months
Change in the size of the thigh muscles
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skeletal muscle fiber size
Time Frame: 6 months
Change in the cross-sectional size of individual thigh skeletal muscle fibers
6 months
Muscle strength
Time Frame: 6 months
Change in the strength/force produced by skeletal muscles of the thigh
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

April 30, 2024

Study Registration Dates

First Submitted

June 5, 2019

First Submitted That Met QC Criteria

June 12, 2019

First Posted (Actual)

June 13, 2019

Study Record Updates

Last Update Posted (Actual)

January 24, 2024

Last Update Submitted That Met QC Criteria

January 23, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Aerobic exercise training

3
Subscribe